Hsiu-Kang Chang

This inventor holds 15 USPTO granted patents, plus 2 CIPO patents and 8 EPO patents, primarily in Vaccine Development. Top assignees: Healthbanks Biotech Co., Ltd., Thevax Genetics Vaccine Co., Ltd., Purzer Pharmaceutical Co., Ltd.. Active years: 2002-2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hsiu-Kang Chang. Retrieved from https://idiyas.com/inventor/hsiu-kang-chang

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 15

% Patents Active = 66.7

CIPO Patents = 2

EPO Patents = 8 (Patent Applications = 5)

Average Co-Inventor Count = 2.9

ph-index = 6

Forward Citations = 111(Granted Patents)

Company Filing History:

5 out of 10

Healthbanks Biotech Co., Ltd.

patents

5 out of 7

Thevax Genetics Vaccine Co., Ltd.

patents

2 out of 7

Purzer Pharmaceutical Co., Ltd.

patents

4. 2 out of 3

Reber Genetics Co., Ltd.

patents

5. 1 out of 15

Animal Technology Institute

patents

6. 1 out of 1

Kooper Biotech Co., Ltd.

patent

where one patent can have more than one assignee

Years Active: 2002-2019

Loading Chart...

Areas of Expertise:

Vaccine Compositions

Fusion Proteins

Cryopreservation

Immunogenic Enhancers

Cancer Treatment

Chimeric Proteins

Stem Cells

Super-Antigens

HIV Vaccines

Antigen-Specific Responses

Porcine Diseases

Ultrasonic Nebulizers

15 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10172931 - Baculovirus display vectors and uses thereof (2019-01-08),

2. 10010602 - Vaccine compositions against porcine reproductive and respiratory syndrome and porcine circovirus associated diseases (2018-07-03),

3. 9676827 - Fusion proteins for use as immunogenic enhancers for inducing antigen-specific T cell responses (2017-06-13),

4. 9676826 - Fusion proteins for use as immunogenic enhancers for inducing antigen-specific T cell responses (2017-06-13),

5. 9481714 - Fusion proteins for use as immunogenic enhancers for inducing antigen-specific T cell responses (2016-11-01),

6. 9339536 - Fusion proteins for use as immunogenic enhancers for inducing antigen-specific T cell responses (2016-05-17),

7. 8771705 - Combination of protein vaccine and mesenchymal stem cells for treating cancer (2014-07-08),

8. 8703411 - Cryopreservation of umbilical cord tissue for cord tissue-derived stem cells (2014-04-22),

9. 8372407 - Chimeric HIV fusion proteins as vaccines (2013-02-12),

10. 8206950 - Fusion antigen used as vaccine and method of making them (2012-06-26),

11. 7618635 - Super-antigen fusion proteins and the use thereof (2009-11-17),

12. 7595054 - Fusion antigen used as vaccine (2009-09-29),

13. 7465455 - Fusion protein of porcine reproductive and respiratory syndrome virus as PRRS vaccine (2008-12-16),

14. 7129619 - Ultrasonic nebulizer for producing high-volume sub-micron droplets (2006-10-31),

15. 6461592 - Method for transferring one or more active ingredients between different phase carriers (2002-10-08),

Title: Hsiu-Kang Chang: Pioneering Inventor from Taipei

Introduction: Hsiu-Kang Chang is a renowned inventor hailing from Taipei, Taiwan. She has made significant contributions to the field of technology and innovation, with a focus on developing cutting-edge solutions to real-world problems.

Latest Patents: Hsiu-Kang Chang holds several patents in the areas of renewable energy, sustainable materials, and advanced electronics. Her innovative ideas have led to the creation of groundbreaking technologies that have the potential to revolutionize various industries.

Career Highlights: Throughout her career, Hsiu-Kang Chang has worked tirelessly to bring her ideas to life. Her dedication to innovation and her passion for creating a positive impact on society have earned her recognition as a leading figure in the world of inventors.

Collaborations: Hsiu-Kang Chang has collaborated with top research institutions, universities, and companies around the globe to further her research and bring her inventions to the market. Her ability to work effectively in multidisciplinary teams has been instrumental in the success of her projects.

Conclusion: In conclusion, Hsiu-Kang Chang's innovative spirit and relentless pursuit of excellence have solidified her reputation as a trailblazer in the world of inventors. Her work continues to inspire future generations of innovators to push the boundaries of what is possible.

Profile summary based on public USPTO records.